Aging and transthyretin-related amyloidosis: Pathologic examinations in pulmonary amyloidosis

Amyloid

Volumn 13, Issue 1, 2006, Pages 24-30

  Ueda, Mitsuharu ^a   Ando, Yukio ^a,d   Haraoka, Katsuki ^a   Katsuragi, Shoichi ^b   Terasaki, Yasuhiro ^a   Sugimoto, Mineharu ^c   Sun, Xuguo ^a   Uchino, Makoto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Kikuchi National Hospital Division of Clinical Research   (Japan)

^c Kumamoto Saishunsou National Hospital   (Japan)

^d Graduate School of Medical Sciences   (Japan)

Author keywords

Aging; FAP; Pulmonary amyloidosis; SSA; TTR

Indexed keywords

PREALBUMIN;

ADULT; AGING; AMYLOIDOSIS; ARTICLE; BRONCHIOLE; BRONCHUS; CLINICAL ARTICLE; DISEASE COURSE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; SENILE AMYLOIDOSIS;

ADULT; AGED, 80 AND OVER; AGING; AMYLOIDOSIS; AMYLOIDOSIS, FAMILIAL; FEMALE; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; POINT MUTATION; PREALBUMIN;

EID: 33646756157     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500537194     Document Type: Article

References (40)

1. Eanes ED, Glenner GG. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 1968;16:673-677.
2. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD. Amyloid fibril protein nomenclature 2002. Amyloid: J Protein Folding Disord 2002;9:197-200.
3. Blake CC, Geisow MJ, Swan ID, Rerat C, Rerat B. Structure of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypepride chain conformation, quaternary structure and thyroxine binding. J Mol Biol 1974;88:1-12.
4. Noy N, Slosberg E, Scarlata S. Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin. Biochemistry 1992;31:11118-11124.
5. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid: J Protein Folding Disord 1996;3:44-56.
6. Strege RJ, Saeger W, Linke RP. Diagnosis and immunohistochemical classification of systemic amyloidosis. Virchows Arch 1998;433:19-27.
7. Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Nad Acad Sci USA 1978;75:4499-4503.
8. Ando Y, Araki S, Ando M. Transthyretin and familial amyloidotic polyneuropathy. Intern Med 1993;32:920-922.
9. Sletten K, Westermark P, Natvig JB. Senile cardiac amyloid is related to prealbumin. Scand J Immunol 1980;12:503-506.
10. Pitkanen P, Westermark P, Cornwell GG 3rd. Senile systemic amyloidosis. Am J Pathol 1984;117:391-399.
11. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Folding Disord 2002;10:160-184.
12. Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983;96:261-270.
13. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-888.
14. Dwulet FE, Benson MD. Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci USA 1984;81:694-698.
15. Gustavsson Å, Engström U, Westermark P. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun 1991;175:1159-1164.
16. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843-2845.
17. Gustavsson Å, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995;73:703-708.
18. Christmanson L, Betsholtz C, Gustavsson Å, Johansson B, Sletten K, Westermark P. The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis. FEBS Lett 1991;281:177-180.
19. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 1984;6:128-133.
20. Ando Y, Suhr O. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid: J Protein Folding Disord 1998;5:288-300.
21. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295-298.
22. Tashima K, Suhr OB, Ando Y, Holmgren G, Yamashita T, Obayashi K, Terazaki H, Uchino M. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met) - comparison of Swedish and Japanese patients. Amyloid: J Protein Folding Disord 1999;6:124-129.
23. Eriksson A, Eriksson P, Olofsson BO, Thornell LE. The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinico-pathologic study of six cases from Northern Sweden. Acta Pathol Microbiol Immunol Scand 1983;91:343-349.
24. Abe M, Ando Y, Higashi K, Kano T. Non-neurogenic periodic fluctuations in heart rate and vasomotion appearing in familial amyloid polyneuropathy (FAP) Type I (Met30). J Auton Nerv Syst 1996;60:71-75.
25. Eriksson P, Olofsson BO. Pacemaker treatment in familial amyloidotic polyneuropathy. Pacing Clin Electrophysiol 1984;7:702-706.
26. Ando Y, Yonehara T, Tanaka Y, Tashima K, Uchino M, Ando M. Early pacemaker implantation in patients with familial amyloidotic polyneuropathy (FAP). Muscle Nerve 1996;19:1640-1641.
27. Skinner M, Lewis WD, Jones LA, Kasirsky J, Kane K, Ju ST, Jenkins R, Falk RH, Simms RW, Cohen AS. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994;120:133-134.
28. Ando Y, Suhr O, Tahsima K, Uchino M, Ando M. Liver transplantation in Japanese patients with familial amyloidotic polyneuropathy. Lancet 1997;350:593-594.
29. Ando Y, Tanaka Y, Nakazato M, Ericzon BG, Yamashita T, Tashima K, Sakashita N, Suga M, Uchino M, Ando M. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 1995;211:354-358.
30. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:113-116.
31. Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M, Ando M. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995;345:195-196.
32. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A, Ando M. De novo amyloid synthesis in the ocular tissue in familial amyloidotic polyneuropathy (FAP) after liver transplantation. Transplantation 1996;62:1037-1038.
33. Ando E, Ando Y, Haraoka K. Vitreous amyloid is formed by transthyretin (TTR) from the retina in familial amyloidotic polyneuropathy (FAP). Ann Intern Med 2001;135:931-932.
34. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80.
35. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
36. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745-751.
37. Hodkinson HM, Pomerance A. The clinical significance of senile cardiac amyloidosis: a prospective clinico-pathological study. Q J Med 1997;46:381-387.
38. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-555.
39. Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type1 in Kumamoto, Japan: A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 1991;22:519-527.
40. Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived systemic amyloidosis: clinico-pathologic and structural considerations. Amyloid: J Protein Folding Disord 2003;10 (Suppl. 1):48-54.